Evan Friedman
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Oncology 8
- Peptidase Inhibition and Analysis 3
-
- HIV/AIDS drug development and treatment 7
- Co-authors
- Marian Iwamoto (10 shared papers)John A. Wagner (8 shared papers)Eric H. Rubin (3 shared papers)Nancy Agrawal (2 shared papers)Keith Gottesdiener (2 shared papers)Julie A. Stone (3 shared papers)Sheila Breidinger (3 shared papers)Larissa Wenning (3 shared papers)
- Journals
- The Journal of Clinical Pharmacology (3 papers)Clinical Cancer Research (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Cancer Research (2 papers)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesCanadaBelgium
In The Last Decade
Evan Friedman
21 papers receiving 540 citations
Peers
Comparison fields: 5 of 72
- Virology 167
- Infectious Diseases 240
- Pharmacology 51
- Oncology 121
- Transplantation 10
Countries citing papers authored by Evan Friedman
This map shows the geographic impact of Evan Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Friedman more than expected).
Fields of papers citing papers by Evan Friedman
This network shows the impact of papers produced by Evan Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Friedman. The network helps show where Evan Friedman may publish in the future.
Co-authors
The 25 scholars most cited alongside Evan Friedman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 94 | |
| 2 | 2020 | 62 | |
| 3 | 2013 | 58 | |
| 4 | 2008 | 57 | |
| 5 | 2010 | 44 | |
| 6 | 2009 | 38 | |
| 7 | 2009 | 37 | |
| 8 | 2009 | 35 | |
| 9 | 2011 | 30 | |
| 10 | 2021 | 29 | |
| 11 | 2019 | 22 | |
| 12 | 2016 | 21 | |
| 13 | 2024 | 6 | |
| 14 | 2021 | 5 | |
| 15 | Abstract #3604: A phase I single-rising dose study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of an oral akt inhibitor in healthy male volunteers | 2009 | 4 |
| 16 | 2014 | 4 | |
| 17 | 2020 | 3 | |
| 18 | 2016 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2024 | 1 |
About Evan Friedman
Evan Friedman is a scholar working on Oncology, Infectious Diseases, Virology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 22 papers that have together received 555 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers), Pharmacogenetics and Drug Metabolism (4 papers), Pharmacological Effects and Toxicity Studies (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Peptidase Inhibition and Analysis (3 papers), Neuroscience and Neural Engineering (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Virology (167 citations), Infectious Diseases (240 citations), Pharmacology (51 citations), Oncology (121 citations) and Transplantation (10 citations). Evan Friedman has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Marian Iwamoto, John A. Wagner, Eric H. Rubin, Nancy Agrawal, Keith Gottesdiener, Julie A. Stone, Sheila Breidinger, Larissa Wenning, Punam Sandhu and S. Aubrey Stoch. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Cancer Research, Antimicrobial Agents and Chemotherapy, Cancer Research and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.